Literature DB >> 21126760

Effects of particle size on toll-like receptor 9-mediated cytokine profiles.

Helen C Chen1, Bingbing Sun, Kenny K Tran, Hong Shen.   

Abstract

Biomaterials interface with toll-like receptor (TLR) 9-mediated innate immunity in a wide range of medical applications, such as tissue implants and drug delivery systems. The stimulation of TLR9 can lead to two different signaling pathways, resulting in the generation of proinflammatory cytokines (i.e. IL-6) and/or type I interferons (IFNs, i.e. IFN-α). These two categories of cytokines differentially influence both innate and adaptive immunity. Although particle size is known to be a critical parameter of biomaterials, its role in TLR9-mediated cytokine profiles is not clear. Here, we examined how the size of biomaterials impacted cytokine profiles by using polystyrene particles of defined sizes as model carriers for TLR9 agonists (CpG oligonucleotides (CpG ODNs)). CpG ODNs bound to nano- to submicro- particles stimulated the production of both IL-6 and IFN-α, while those bound to micro particles resulted in IL-6 secretions only. The differential TLR9-mediated cytokine profiles were attributed to the pH of endosomes that particles trafficked to. The magnitude of IFN-α production was highly sensitive to the change in endosomal pH in comparison to that of IL-6. Our results define two critical design variables, size and the ability to modulate endosomal pH, for the engineering of biomaterials that potentially interface with TLR9-mediated innate immunity. The fine control of these two variables will allow us to fully exploit the beneficial facets of TLR9-mediated innate immunity while minimizing undesirable side effects. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126760      PMCID: PMC3031083          DOI: 10.1016/j.biomaterials.2010.10.059

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  68 in total

1.  The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation.

Authors:  Viktoriya Sokolova; Torben Knuschke; Anna Kovtun; Jan Buer; Matthias Epple; Astrid Maria Westendorf
Journal:  Biomaterials       Date:  2010-04-24       Impact factor: 12.479

2.  Spatiotemporal regulation of heat shock protein 90-chaperoned self-DNA and CpG-oligodeoxynucleotide for type I IFN induction via targeting to static early endosome.

Authors:  Koichi Okuya; Yasuaki Tamura; Keita Saito; Goro Kutomi; Toshihiko Torigoe; Koichi Hirata; Noriyuki Sato
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

3.  Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Authors:  Richard B Pyles; Debbie Higgins; Claudia Chalk; Anthony Zalar; Joseph Eiden; Carrie Brown; Gary Van Nest; Lawrence R Stanberry
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3.

Authors:  Miwa Sasai; Melissa M Linehan; Akiko Iwasaki
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

5.  Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes.

Authors:  Alison J Lin; Nelle L Slack; Ayesha Ahmad; Cyril X George; Charles E Samuel; Cyrus R Safinya
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

6.  Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

Authors:  Ali A Ashkar; Stefan Bauer; William J Mitchell; Jeff Vieira; Kenneth L Rosenthal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.

Authors:  Kenny K Tran; Hong Shen
Journal:  Biomaterials       Date:  2008-12-16       Impact factor: 12.479

8.  Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants.

Authors:  Yasunobu Tamaki; Yuya Takakubo; Kaoru Goto; Tomoyuki Hirayama; Kan Sasaki; Yrjö T Konttinen; Stuart B Goodman; Michiaki Takagi
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666

9.  Immunostimulatory characteristics induced by linear polyethyleneimine-plasmid DNA complexes in cultured macrophages.

Authors:  Yasunori Saito; Yuriko Higuchi; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

10.  Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.

Authors:  Jennifer Lund; Ayuko Sato; Shizuo Akira; Ruslan Medzhitov; Akiko Iwasaki
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  12 in total

1.  DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways.

Authors:  Eric A Levenson; Kristi L Kiick
Journal:  Acta Biomater       Date:  2013-12-06       Impact factor: 8.947

2.  Buffering capacity and size of siRNA polyplexes influence cytokine levels.

Authors:  Qixin Leng; Szu-Ting Chou; Puthupparampil V Scaria; Martin C Woodle; A James Mixson
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

3.  Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation.

Authors:  Paschalia M Mountziaris; Stephanie N Tzouanas; David C Sing; Phillip R Kramer; F Kurtis Kasper; Antonios G Mikos
Journal:  Acta Biomater       Date:  2012-06-28       Impact factor: 8.947

4.  pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

Authors:  John T Wilson; Salka Keller; Matthew J Manganiello; Connie Cheng; Chen-Chang Lee; Chinonso Opara; Anthony Convertine; Patrick S Stayton
Journal:  ACS Nano       Date:  2013-04-30       Impact factor: 15.881

5.  Selectively targeting the toll-like receptor 9 (TLR9)--IRF 7 signaling pathway by polymer blend particles.

Authors:  Helen C Chen; Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Biomaterials       Date:  2013-06-05       Impact factor: 12.479

Review 6.  Biodegradable calcium phosphate nanoparticles for cancer therapy.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  Adv Colloid Interface Sci       Date:  2020-04-10       Impact factor: 12.984

7.  Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects.

Authors:  Gertie J Oostingh; Eudald Casals; Paola Italiani; Renato Colognato; René Stritzinger; Jessica Ponti; Tobias Pfaller; Yvonne Kohl; Daniëlla Ooms; Flavia Favilli; Hilde Leppens; Davide Lucchesi; François Rossi; Inge Nelissen; Hagen Thielecke; Victor F Puntes; Albert Duschl; Diana Boraschi
Journal:  Part Fibre Toxicol       Date:  2011-02-09       Impact factor: 9.400

Review 8.  Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2012-04-27

9.  Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines.

Authors:  Huijie Zhang; Song Chen; Chunyi Zhi; Tomohiko Yamazaki; Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2013-05-06

10.  Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy.

Authors:  Adam Yuh Lin; Joao Paulo Mattos Almeida; Adham Bear; Nathan Liu; Laureen Luo; Aaron Edward Foster; Rebekah Anna Drezek
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.